FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2081496413> ?p ?o ?g. }

• W2081496413 endingPage "232" @default.
• W2081496413 startingPage "227" @default.
• W2081496413 abstract "Background. Timely transplantation of sensitized kidney recipients remains a challenge. Patients with a complement-dependent cytotoxicity negative and flow cytometry (FC) positive crossmatch carry increased risk of antibody-mediated rejection and thus graft loss. Solid phase assays are available to confirm donor specificity for antibody identified by FC crossmatch. Treatment using induction therapy with rabbit antithymocyte globulin (RATG) and intravenous immunoglobulin (IVIG) may allow successful transplant of these high-risk patients. Methods. A retrospective study of 264 consecutive patients after exclusions yielded 94 complement-dependent cytotoxicity anti-human globulin crossmatch-negative patients, including group 1: 58 primary transplants with panel-reactive antibody (PRA) less than 20%, group 2: 16 retransplants and PRA more than 20% who were FC crossmatch-negative, and group 3: 20 retransplants and PRA more than 20% who were FC crossmatch-positive. All were treated with RATG induction and maintenance therapy with tacrolimus, mycophenolate mofetil, and corticosteroids. Only group 3 received IVIG at 500 mg/kg daily in three doses. Results. Eighteen of 20 patients in group 3 had donor-specific antibody identified by solid phase assay. Cellular- and antibody-mediated rejections were statistically higher in group 3. Two-year serum creatinine and glomerular filtration rate along with 3-year patient and graft survival were comparable between the groups. Conclusions. Sensitized patients with positive FC crossmatch and donor-specific antibody identified by solid phase assays can be successfully transplanted using standard RATG induction, IVIG, and maintenance immunosuppression with equal renal function and graft survival to immunologically lower risk recipients. Given these results, this patient group should not be excluded from transplantation based on antibody specificities determined by virtual crossmatch techniques." @default.
• W2081496413 created "2016-06-24" @default.
• W2081496413 creator A5009395138 @default.
• W2081496413 creator A5015694544 @default.
• W2081496413 creator A5018917062 @default.
• W2081496413 creator A5034104462 @default.
• W2081496413 creator A5034544046 @default.
• W2081496413 creator A5046333051 @default.
• W2081496413 creator A5050228731 @default.
• W2081496413 creator A5058661921 @default.
• W2081496413 creator A5066983919 @default.
• W2081496413 creator A5079598927 @default.
• W2081496413 creator A5091061621 @default.
• W2081496413 creator A5091897464 @default.
• W2081496413 date "2009-01-27" @default.
• W2081496413 modified "2023-10-15" @default.
• W2081496413 title "Excellent Renal Allograft Survival in Donor-Specific Antibody Positive Transplant Patients—Role of Intravenous Immunoglobulin and Rabbit Antithymocyte Globulin" @default.
• W2081496413 cites W1979110891 @default.
• W2081496413 cites W1987247776 @default.
• W2081496413 cites W1988814676 @default.
• W2081496413 cites W1995791071 @default.
• W2081496413 cites W2012512164 @default.
• W2081496413 cites W2012742189 @default.
• W2081496413 cites W2017511990 @default.
• W2081496413 cites W2021005241 @default.
• W2081496413 cites W2021227791 @default.
• W2081496413 cites W2021823787 @default.
• W2081496413 cites W2025090997 @default.
• W2081496413 cites W2035061164 @default.
• W2081496413 cites W2038713426 @default.
• W2081496413 cites W2041260540 @default.
• W2081496413 cites W2045251171 @default.
• W2081496413 cites W2047848982 @default.
• W2081496413 cites W2053465471 @default.
• W2081496413 cites W2060214204 @default.
• W2081496413 cites W2069347371 @default.
• W2081496413 cites W2070076886 @default.
• W2081496413 cites W2075778171 @default.
• W2081496413 cites W2079246366 @default.
• W2081496413 cites W2084973436 @default.
• W2081496413 cites W2089290166 @default.
• W2081496413 cites W2093399787 @default.
• W2081496413 cites W2106831081 @default.
• W2081496413 cites W2110079652 @default.
• W2081496413 cites W2131506846 @default.
• W2081496413 cites W2131708234 @default.
• W2081496413 cites W2169424666 @default.
• W2081496413 cites W2333378480 @default.
• W2081496413 doi "https://doi.org/10.1097/tp.0b013e31818c962b" @default.
• W2081496413 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19155977" @default.
• W2081496413 hasPublicationYear "2009" @default.
• W2081496413 type Work @default.
• W2081496413 sameAs 2081496413 @default.
• W2081496413 citedByCount "37" @default.
• W2081496413 countsByYear W20814964132012 @default.
• W2081496413 countsByYear W20814964132013 @default.
• W2081496413 countsByYear W20814964132014 @default.
• W2081496413 countsByYear W20814964132015 @default.
• W2081496413 countsByYear W20814964132016 @default.
• W2081496413 countsByYear W20814964132017 @default.
• W2081496413 countsByYear W20814964132023 @default.
• W2081496413 crossrefType "journal-article" @default.
• W2081496413 hasAuthorship W2081496413A5009395138 @default.
• W2081496413 hasAuthorship W2081496413A5015694544 @default.
• W2081496413 hasAuthorship W2081496413A5018917062 @default.
• W2081496413 hasAuthorship W2081496413A5034104462 @default.
• W2081496413 hasAuthorship W2081496413A5034544046 @default.
• W2081496413 hasAuthorship W2081496413A5046333051 @default.
• W2081496413 hasAuthorship W2081496413A5050228731 @default.
• W2081496413 hasAuthorship W2081496413A5058661921 @default.
• W2081496413 hasAuthorship W2081496413A5066983919 @default.
• W2081496413 hasAuthorship W2081496413A5079598927 @default.
• W2081496413 hasAuthorship W2081496413A5091061621 @default.
• W2081496413 hasAuthorship W2081496413A5091897464 @default.
• W2081496413 hasBestOaLocation W20814964131 @default.
• W2081496413 hasConcept C126322002 @default.
• W2081496413 hasConcept C126894567 @default.
• W2081496413 hasConcept C159641895 @default.
• W2081496413 hasConcept C159654299 @default.
• W2081496413 hasConcept C203014093 @default.
• W2081496413 hasConcept C2777726029 @default.
• W2081496413 hasConcept C2780252810 @default.
• W2081496413 hasConcept C2780303639 @default.
• W2081496413 hasConcept C2780306776 @default.
• W2081496413 hasConcept C2909675724 @default.
• W2081496413 hasConcept C2911091166 @default.
• W2081496413 hasConcept C40677261 @default.
• W2081496413 hasConcept C542903549 @default.
• W2081496413 hasConcept C64518967 @default.
• W2081496413 hasConcept C71924100 @default.
• W2081496413 hasConcept C81358767 @default.
• W2081496413 hasConcept C90924648 @default.
• W2081496413 hasConceptScore W2081496413C126322002 @default.
• W2081496413 hasConceptScore W2081496413C126894567 @default.
• W2081496413 hasConceptScore W2081496413C159641895 @default.
• W2081496413 hasConceptScore W2081496413C159654299 @default.
• W2081496413 hasConceptScore W2081496413C203014093 @default.
• W2081496413 hasConceptScore W2081496413C2777726029 @default.

• next